Indication
Hypotrichosis of eyelid lashes
Hypotrichosis of eyelid lashes describes an integumentary and ocular adnexal condition characterized by an inadequate amount, density, length, or thickness of the cilia along the eyelid margins. Read more about Hypotrichosis of eyelid lashes
2 drugs 2 manufacturers
Drugs that treat it
Common Hypotrichosis of eyelid lashes therapies.
BIMATOPROST
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonHypotrichosis of eyelid lashes describes an integumentary and ocular adnexal condition characterized by an inadequate amount, density, length, or thickness of the cilia along the eyelid margins.
It may present congenitally as part of genetic ectodermal syndromes or arise as an acquired state secondary to aging, localized eyelid inflammation such as blepharitis, mechanical trauma, chemotherapy, or systemic alopecia.
Pathophysiologically, the condition involves follicular dysfunction marked by shortened anagen growth phases, prolonged telogen resting intervals, or diminished follicular miniaturization.
Clinically, affected individuals exhibit sparse, fine, or absent eyelashes, which can compromise the natural ocular barrier against foreign debris and moisture while impacting facial aesthetics.
- fda.gov
Hypotrichosis of eyelid lashes describes an integumentary and ocular adnexal condition characterized by an inadequate amount, density, length, or thickness of the cilia along the eyelid margins
- nih.gov
Hypotrichosis of eyelid lashes describes an integumentary and ocular adnexal condition characterized by an inadequate amount, density, length, or thickness of the cilia along the eyelid margins It may present congenitally as part of genetic ectodermal syndromes or arise as an acquired state secondary to aging, localized eyelid inflammation such as blepharitis, mechanical trauma, chemotherapy, or systemic alopecia Pathophysiologically, the condition involves follicular dysfunction marked by short...
- eyecliniclondon.com
It may present congenitally as part of genetic ectodermal syndromes or arise as an acquired state secondary to aging, localized eyelid inflammation such as blepharitis, mechanical trauma, chemotherapy, or systemic alopecia
- premiumrxdrugs.com
Pathophysiologically, the condition involves follicular dysfunction marked by shortened anagen growth phases, prolonged telogen resting intervals, or diminished follicular miniaturization Clinically, affected individuals exhibit sparse, fine, or absent eyelashes, which can compromise the natural ocular barrier against foreign debris and moisture while impacting facial aesthetics
Personalize your experience
Follow Hypotrichosis of eyelid lashes and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.